Benzinga | Jan 20, 2022 07:50AM EST

Radius Pharmaceuticals Filed U.S. Patent Application #20220016052 'METHODS FOR TREATING CANCER IN MODELS HARBORING ESR1 MUTATIONS'

View Patent Application here